Skip to main content
SHENZHEN NEPTUNUS BIOENGINEERING CO.,LTD logo

SHENZHEN NEPTUNUS BIOENGINEERING CO.,LTD — Investor Relations & Filings

Ticker · 000078 ISIN · CNE000000X95 LEI · 300300J4GCOV7CYQTB51 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,616 across all filing types
Latest filing 2024-01-14 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 000078

About SHENZHEN NEPTUNUS BIOENGINEERING CO.,LTD

https://www.neptunusbio.com

Shenzhen Neptunus Bioengineering Co., Ltd. is a comprehensive healthcare enterprise focused on the research, development, manufacturing, and distribution of pharmaceutical products. The company operates across the entire industry value chain, including the production of chemical drugs, biological preparations, and traditional Chinese medicines. Its portfolio extends to medical devices and health supplements. A significant component of its operations involves a large-scale pharmaceutical distribution network and a nationwide retail pharmacy chain. The company emphasizes innovation in biotechnology and maintains modern production facilities to support its diverse product lines. By integrating R&D with a robust logistics and retail infrastructure, it provides a wide range of healthcare solutions to medical institutions and consumers.

Recent filings

Filing Released Lang Actions
关于控股股东签署附交易生效条件的合作协议书的提示性公告
Capital/Financing Update Classification · 95% confidence The document is an announcement by Shenzhen Haiwang Bioengineering Co., Ltd. regarding a cooperation agreement signed by its controlling shareholder for a conditional share transfer transaction. It details the parties involved, the transaction terms, approvals required, and risk warnings. The document does not contain financial statements or detailed financial performance data. It is primarily an update on a capital transaction involving share transfer and related approvals. Therefore, it fits the category of Capital/Financing Update (CAP). The document length is sufficient and contains substantive information about the transaction rather than just a brief notice or report publication announcement.
2024-01-14 Chinese
关于筹划重大事项的进展公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from Shenzhen Haiwang Bioengineering Co., Ltd. regarding the progress of planning a major transaction. It mentions the company's disclosure obligations under relevant laws and regulations, the ongoing due diligence and negotiation process with strategic investors, and the uncertainty and risks associated with the transaction. The document does not contain financial statements or detailed financial data but is a progress update on a significant corporate event, specifically a major asset restructuring and mixed-ownership reform. It is not a full report, earnings release, or regulatory certification. The content fits the category of a Capital/Financing Update (CAP) as it relates to significant financing and restructuring activities and their progress.
2023-12-29 Chinese
关于NEP018获得美国FDA批准进入人体临床试验的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement by Shenzhen Haier Bioengineering Co., Ltd. regarding the approval by the US FDA for their drug NEP018 to enter Phase I clinical trials. It includes details about the drug, its development status, and potential impact on the company. The document is short (1067 characters) and serves as a regulatory announcement about a clinical trial approval, not a financial report or detailed management discussion. It does not contain financial data, earnings, or governance information. It is an official announcement related to regulatory approval and company operations, fitting best under Regulatory Filings (RNS).
2023-12-29 Chinese
关于变更职工代表监事的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the resignation of a company's employee representative supervisor and the election of a new supervisor. It includes details about the new supervisor's background and confirms compliance with relevant laws and regulations. There is no financial data, no mention of financial results, no report publication, and no regulatory certification. The content focuses on changes in the company's supervisory board members, which fits the category of Board/Management Information (MANG). The document length is short and it is clearly an announcement of a management change rather than a full report or other filing type.
2023-12-29 Chinese
第九届董事局第十一次会议决议公告
Board/Management Information Classification · 95% confidence The document is an announcement of resolutions passed at a board meeting of Shenzhen Haiwang Bioengineering Co., Ltd. It details the meeting date, attendance, and voting results on board committee adjustments and senior management changes. It references other announcements for details on these changes. The content focuses on board and senior management changes rather than financial results or reports. Therefore, it fits the category of Board/Management Information (MANG). The document length is short and it is not a full report but an announcement of board decisions.
2023-12-25 Chinese
关于调整董事局专业委员会委员的公告
Board/Management Information Classification · 100% confidence The document is an announcement from Shenzhen Haiwang Bioengineering Co., Ltd. regarding adjustments to the members of the company's board committees, including the audit committee, nomination committee, and remuneration and assessment committee. It details changes in committee membership and confirms the board resolution. There is no financial data, no mention of annual or interim reports, earnings, or other financial disclosures. The content focuses solely on board/management structure changes. Therefore, this fits the category of Board/Management Information (MANG). The document length is short and it is a direct announcement, not a report publication or certification.
2023-12-25 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.